SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-20-003017
Filing Date
2020-04-29
Accepted
2020-04-29 16:10:18
Documents
6
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a_042920.htm DEFA14A 10876
2 GRAPHIC logo.jpg GRAPHIC 6330
3 GRAPHIC proxy_1.jpg GRAPHIC 934052
4 GRAPHIC proxy_2.jpg GRAPHIC 1180527
5 GRAPHIC proxy_3.jpg GRAPHIC 553988
6 GRAPHIC proxy_4.jpg GRAPHIC 427191
  Complete submission text file 0001171843-20-003017.txt   4284925
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 20830368
SIC: 3841 Surgical & Medical Instruments & Apparatus